Deepening a recent split among judges in the Eastern District of Pennsylvania, U.S. District Senior Judge Michael Baylson has remanded a case against GlaxoSmithKline over its antidepressant drug Paxil, ruling it should be tried in the Philadelphia Court of Common Pleas. GSK had argued the case belonged in federal court.
The pharmaceutical giant had sought removal of the case, for the second time, after the U.S. Court of Appeals for the Third Circuit’s ruling in June that declared its corporate citizenship lay in Delaware. Arguing that the opinion constitutes an intervening order, it asked to have several suits alleging birth defects caused by Paxil removed to federal court on diversity grounds.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]